| Released | Contributor | Author | Title | Pages | Price |
| 8-Dec-2009 | Pechala's Reports | Lubomir Pechala | NXSTAGE MEDICAL INC (NXTM=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 7-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for NXTM | 13 |
$25 |
| 7-Dec-2009 | Market Edge |
N/A
| Market Edge Equity Research Report | 4 |
$10 |
| 6-Dec-2009 | PriceTarget Research, Inc. |
N/A
| NxStage Medical has a current Overall Rating of C (Neutral). | 7 |
$25 |
| 5-Dec-2009 | PriceTarget Research, Inc. |
N/A
| Health Serv & Equipment Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 25 new Laggards. | 65 |
$20 |
| 5-Dec-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: NXSTAGE MEDICAL INC | 5 |
$25 |
| 5-Dec-2009 | Standard & Poor's Quantitative Report |
N/A
| NxStage Medical | 6 |
$25 |
| 4-Dec-2009 | Pechala's Reports | Frantisek Pechala | NXSTAGE MEDICAL INC (NXTM=US) 12-months forecast | 1 |
$15 |
| 4-Dec-2009 | Pechala's Reports | Lubomir Pechala | NXSTAGE MEDICAL INC (NXTM=US) 2-weeks forecast | 1 |
$10 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: CLRT , LMAT , LMNX , MLAB , MEND , NXTM , PMTI -- MEDICAL SUPPLIES & EQUIPMENT | 3 |
$4 |
0.01% Nasdaq 0.00%
Research Reports
